Artikel: [Clinical efficacy of Manlyman Spray combined with biofeedback therapy on premature ejaculation].
Zhonghua nan ke xue = National journal of andrology
2024 Band 29, Heft 7, Seite(n) 630–633
Abstract: Objective: To observe the clinical effect of Manlyman Spray combined with biofeedback therapy in the treatment of premature ejaculation (PE).Methods: A total of 60 primary premature ejaculation patients with stable sexual partners and regular sexual ... ...
Abstract | Objective: To observe the clinical effect of Manlyman Spray combined with biofeedback therapy in the treatment of premature ejaculation (PE).Methods: A total of 60 primary premature ejaculation patients with stable sexual partners and regular sexual activity (≥1 times per week) from April 2021 to October 2022 were involved in the clinical observation, The patients' age is (34.3 ± 4.9) years old, and the course of the disease is (112.5 ± 65.5) months, and Manlyman Spray combined with biofeedback therapy was used to treat patients for 8 weeks. Manlyman Spray was sprayed 3 times on the surface of the penisqd for 4 weeks, and Biofeedback therapy is treated twice a week according to the AI setting module, for a total of 8 weeks. Before and 8 weeks after medication and at 4 weeks after drug withdrawal, the Intravaginal Ejaculation Latency Time (IELT), Premature Ejaculation Diagnostic Tool (PEDT) scores and Clinical Global Impression of Change (CGIC) scores were Obtained and compared. Results: After 8 weeks of treatment, the IELT of the patients was significantly prolonged ([351.4 ± 76.7] vs [87 ± 16.8],P<0.05) and at 4 weeks after drug withdrawal, the therapeutic effect still existed ([345.9 ± 80.3] vs [87 ± 16.8],P<0.05), the PEDT scores were significantly improved after treatment ([18.2 ± 1.1] vs [9.0 ± 1.4],P<0.05)and at 4 weeks after drug withdrawal([18.0 ± 1.2] vs [9.0 ± 1.4],P<0.05), and so were the CGIC scores ([13.4 ± 1.3] vs [3.3 ± 1.4],P<0.05, and [12.6 ± 1.6] vs [3.3 ± 1.4],P<0.05). Conclusion: The combination of Manlyman Spray and biofeedback therapy can effectively treat primary premature ejaculation, with a long duration of treatment and good safety, and the specific mechanism needs further study. |
---|---|
Mesh-Begriff(e) | Male ; Humans ; Adult ; Premature Ejaculation/therapy ; Biofeedback, Psychology ; Treatment Outcome ; Ejaculation ; Sexual Behavior |
Sprache | Chinesisch |
Erscheinungsdatum | 2024-04-15 |
Erscheinungsland | China |
Dokumenttyp | English Abstract ; Journal Article |
ZDB-ID | 2267480-9 |
ISSN | 1009-3591 |
ISSN | 1009-3591 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 6577: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.